Prospective randomized comparison of 1-week RBC triple therapy versus 1-week PPI triple therapy for H-pylori-related duodenal ulcers.

被引：0
|
作者：
Sung, JY
Leung, WK
Ling, TKW
Yung, MY
Chan, KL
Lee, YT
Chung, SCS
Cheng, AFB
机构：
[1] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med, Sha Tin 100083, Hong Kong
[2] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Microbiol, Sha Tin 100083, Hong Kong
[3] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Surg, Sha Tin 100083, Hong Kong
来源：
GASTROENTEROLOGY | 1998年 / 114卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
G1216
引用
收藏
页码：A296 / A297
页数：2
相关论文
共 50 条
  • [21] A multicentre study on eradication of Helicobacter pylori using four 1-week triple therapies in China
    Xiao, SD
    Liu, WZ
    Hu, PJ
    Ouyang, Q
    Wang, JL
    Zhou, LY
    Cheng, NN
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2001, 15 (01) : 81 - 86
  • [22] The GU-MACH study:: the effect of 1-week omeprazole triple therapy on Helicobacter pylori infection in patients with gastric ulcer
    Malfertheiner, P
    Bayerdörffer, E
    Diete, U
    Gil, J
    Lind, T
    Misiuna, P
    O'Morain, C
    Sipponen, P
    Spiller, RC
    Stasiewicz, J
    Treichel, HC
    Ujszászy, L
    Unge, P
    Van Zanten, SJOV
    Zeijlon, L
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1999, 13 (06) : 703 - 712
  • [23] Is 1-week proton pump inhibitor-based triple therapy sufficient to heal peptic ulcer?
    Gisbert, JP
    Pajares, JM
    [J]. HELICOBACTER, 2005, 10 (05) : 531 - 531
  • [24] Second-line Helicobacter pylori Eradication: A Randomized Comparison of 1-week or 2-week Bismuth-containing Quadruple Therapy
    Chung, Jun-Won
    Lee, Jeong Hoon
    Jung, Hwoon-Yong
    Yun, Sung-Cheol
    Oh, Tae-Hoon
    Choi, Kee Don
    Song, Ho June
    Lee, Gin Hyug
    Kim, Jin-Ho
    [J]. HELICOBACTER, 2011, 16 (04) : 289 - 294
  • [25] Comparison of two 1-week low-dose omeprazole triple therapies - optimal treatment for Helicobacter pylori infection?
    Goh, KL
    Parasakthi, N
    Chuah, SY
    Cheah, PL
    Lo, YL
    Chin, SC
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1997, 11 (06) : 1115 - 1118
  • [26] The MACH2 study:: Role of omeprazole in eradication of Helicobacter pylori with 1-week triple therapies
    Lind, T
    Mégraud, F
    Unge, P
    Bayerdörffer, E
    O'Morain, C
    Spiller, R
    van Zanten, SV
    Bardhan, KD
    Hellblom, M
    Wrangstadh, M
    Zeijlon, L
    Cederberg, C
    [J]. GASTROENTEROLOGY, 1999, 116 (02) : 248 - 253
  • [27] The effect of 1-week esomeprazole (nexium®)-based triple therapy for Helicobacter pylori eradication in patients with duodenal ulcer.: An open non-ramdomized study.
    Luman, W
    Ng, HS
    [J]. GASTROENTEROLOGY, 2005, 128 (04) : A563 - A563
  • [28] A PROSPECTIVE RANDOMIZED TRIAL OF SCHEDULES FOR SCLEROSING ESOPHAGEAL-VARICES - 1-WEEK VERSUS 2-WEEK INTERVALS
    HIGASHI, H
    KITANO, S
    HASHIZUME, M
    YAMAGA, H
    SUGIMACHI, K
    [J]. HEPATO-GASTROENTEROLOGY, 1989, 36 (05) : 337 - 340
  • [29] Head-to-head comparison of 1-week triple regimens combining ranitidine or omeprazole with two antibiotics to eradicate Helicobacter pylori.
    Savarino, V
    Zentilin, P
    Bisso, G
    Pivari, M
    Mele, MR
    Mela, GS
    Mansi, C
    Vigneri, S
    Termini, R
    Celle, G
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1999, 13 (05) : 643 - 649
  • [30] Efficacy and safety of 1-week Helicobacter pylori eradication therapy and 7-week rebamipide treatment after endoscopic submucosal dissection of early gastric cancer in comparison with 8-week PPI standard treatment: a randomized, controlled, prospective, multicenter study
    Higuchi, Kazuhide
    Takeuchi, Toshihisa
    Uedo, Noriya
    Takeuchi, Yoji
    Naito, Yuji
    Yagi, Nobuaki
    Tominaga, Kazunari
    Machida, Hirohisa
    Tamada, Takashi
    Morita, Yoshinori
    Yazumi, Shujiro
    Yamao, Junichi
    Iguchi, Mikitaka
    Azuma, Takeshi
    [J]. GASTRIC CANCER, 2015, 18 (03) : 612 - 617
12345